0001415889-14-003295.txt : 20141103 0001415889-14-003295.hdr.sgml : 20141103 20141103163404 ACCESSION NUMBER: 0001415889-14-003295 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141103 DATE AS OF CHANGE: 20141103 EFFECTIVENESS DATE: 20141103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-227594 FILM NUMBER: 141189888 BUSINESS ADDRESS: STREET 1: 1410 BROADWAY, 23RD FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10018 BUSINESS PHONE: 917-842-2353 MAIL ADDRESS: STREET 1: 1410 BROADWAY, 23RD FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 D 1 primary_doc.xml X0707 D LIVE 0001604191 AzurRx BioPharma, Inc. 1410 Broadway 23rd Floor New York NY NEW YORK 10018 (646) 699-7855 DELAWARE BioPharma dAzur, Inc. BioPharma d'Azur, Inc. Corporation true 2014 Johan (Thijs) Spoor c/o AzurRx BioPharma, Inc. 1410 Broadway, 23 Floor New York NY NEW YORK 10018 Director Christine Rigby c/o AzurRx BioPharma, Inc. 1410 Broadway, 23 Floor New York NY NEW YORK 10018 Executive Officer Matthew Balk c/o AzurRx BioPharma, Inc. 1410 Broadway, 23 Floor New York NY NEW YORK 10018 Promoter Biotechnology Decline to Disclose 06b false 2014-10-14 false true true true false 0 Alexander Capital, LP 40077 None None 17 State Street 5th Floor New York NY NEW YORK 10004 IL ILLINOIS NJ NEW JERSEY PA PENNSYLVANIA 7000000 284000 6716000 false 0 3 12000 0 20000 true Proceeds will be used for payroll and expense reimbursements. AzurRx BioPharma, Inc. /s/ Christine Rigby Christine Rigby President 2014-11-03